Table 2 of Stunf, Mol Vis 2012; 18:2909-2914.

Age at the time of aqueous tap, gender | Vaccination against RV | GWC | ||||
---|---|---|---|---|---|---|

RV | HSV | VZV | CMV | Toxo | ||

59, M | no | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |

48, M | no | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |

46, M | no | <3/Neg | <3/Neg | <3/Neg | 15,64/Pos | <3/Neg |

35, F | 12 yo | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |

33, F | 12 yo | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |

38, F | 12 yo | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |

25, M | no | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |

54, M | no | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |

57, M | no | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |

44, M | no | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |

47, F | no | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |

32, F | 12 yo | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |